Epigenetic marks include DNA methylation and histone modifications (eg. histone methylation and acetylation). Epigenica is an all-in-one solution as it can perform assays of both DNA methylation and histone modifications meaning increased speed and cost-efficiency.
The market will reach USD 21.7 billion by 2026. Growing prevalence of cancer and other diseases across the globe, along with epigenetic modification base, is anticipated to fuel the industry growth. Epigenica provides a platform technology that would speed up and lower the costs of epigenetic diagnostics.